Aclarubicin
An anthracycline antibiotic with antineoplastic activity.
General information
Aclarubicin on PubChem
CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O
Supporting references
Link | Tested on | Impact factor | Notes | Publication date |
---|---|---|---|---|
Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation
3CLpro Small molecule In silico |
in silico | 4.00 | Predicted to inhibit the SARS-CoV-2 3C-like protease. |
Oct/19/2020 |